Moment: Why Prostate Cancer Screening Is More Confusing Than Ever
In this episode, Dr. Rena Malik, MD and Dr. Scott Eggener discuss the nuances of prostate cancer screening, including PSA testing, individualized risk assessment, and recent guideline changes. They highlight advancements in diagnostic tools and clarify which prostate cancers require treatment, offering valuable insights to help listeners make informed decisions about their prostate health.
Listen on
In this episode, Dr. Rena Malik, MD and Dr. Scott Eggener explore the complexities of prostate cancer screening, discussing personalized risk assessment, PSA testing, and the evolving guidelines on when to start and stop screening. They break down the latest advancements in biomarker and MRI technology, clarify the distinction between low-risk "wimpy" cancers and those requiring treatment, and emphasize the importance of shared decision-making between doctors and patients. Listeners will gain up-to-date knowledge on navigating prostate cancer screening, understanding biopsy innovations, and making informed choices about their health.
00:00 PSA Screening Basics
02:01 When to Start and How Often to Screen
04:41 When to Stop PSA Screening
08:00 What Happens After an Elevated PSA
11:04 Biomarkers, MRI, and Next Steps
15:15 Prostate Biopsy Options and Advances
19:15 Understanding Low-Risk vs Serious Prostate Cancer
WEBSITE: http://www.renamalikmd.com
YOUTUBE: https://www.youtube.com/@RenaMalikMD
INSTAGRAM: http://www.instagram.com/RenaMalikMD
TWITTER: http://twitter.com/RenaMalikMD
FACEBOOK: https://www.facebook.com/RenaMalikMD/
LINKEDIN: https://www.linkedin.com/in/renadmalik
PINTEREST: https://www.pinterest.com/renamalikmd/
TIKTOK: https://www.tiktok.com/RenaMalikMD
Premium Member Content
Full transcripts are available to Premium members.
Become a member to read the complete transcript of this episode (and every episode), plus get ad-free listening, member-only content, and behind-the-scenes access.